Work

Cavin-4 peptide immunization induces autoimmunity with features of immune-mediated rippling muscle disease

Year: 2026
Type: article
Abstract: Cavin-4 has recently been identified as a target autoantigen in immune-mediated rippling muscle disease (iRMD); however, direct in vivo evidence linking cavin-4 directed immunity to muscle dysfunction is lacking. We therefore evaluated whether cavin-4 peptide immunization could induce cavin-4-directed autoimmunity and generate immunologic and muscle-related features associated with iRMD in mice. Wild-type C57BL/6 mice were immunized with mouse or human cavin-4 peptides (n=10/group); age-matched, unimmunized mice served as controls (n=5). Cavin-4 autoantibodies developed in both immunized groups, with stronger humoral responses in human peptide-immunized mice by ELISA and broader cavin-4 peptide enrichment by PhIP-Seq. Sera from human peptide-immunized mice recognized native cavin-4 on live C2C12 myotubes and were associated with impaired hanging-wire performance, elevated CK levels, mosaic reduction of cavin-4 immunoreactivity in skeletal muscle, and enhanced antigen-specific T-cell responses. These findings demonstrate that cavin-4 peptide immunization can induce biologically active, cavin-4-directed autoimmunity associated with functional, biochemical, and tissue-level abnormalities, although overt muscle rippling was not observed.
Institution: Mayo Clinic
Language: English
Subfield: Rheumatology
Field: Medicine
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7226037430
FWCI:
Cites: 11
Cited by:
Related to: 10
Parts: 7